Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NPY and cardiac diseases.

B J McDermott1, D Bell

  • 1Therapeutics & Pharmacology, Queen's University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland. b.mcdermott@qub.ac.uk

Current Topics in Medicinal Chemistry
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intention.

Journal of tissue viability·2025
Same author

My assistive technology outcomes framework: Rights-based outcome tools for consumers to 'measure what matters'.

Assistive technology : the official journal of RESNA·2023
Same author

Guest Editorial - A personal journey in Acute Medicine.

Acute medicine·2022
Same author

Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same author

COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.

The Journal of infection·2020
Same author

Is scan-negative cauda equina syndrome a functional neurological disorder? A pilot study.

European journal of neurology·2020
Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
Same journal

Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42.

Current topics in medicinal chemistry·2026
See all related articles

Neuropeptide Y (NPY) influences cardiac remodeling and function, potentially contributing to heart failure. Understanding NPY

Area of Science:

  • Cardiovascular Research
  • Neuroendocrinology
  • Molecular Cardiology

Background:

  • Hypertension-induced left ventricular hypertrophy (LVH) and ischemic heart disease lead to cardiac remodeling and heart failure.
  • Current neurohormonal treatments for cardiac conditions have limitations.
  • Neuropeptide Y (NPY) is implicated in cardiac sympathetic nerve activity, coronary function, and myocardial contraction.

Purpose of the Study:

  • To review the role of Neuropeptide Y (NPY) in cardiac pathology.
  • To explore NPY's contribution to myocardial remodeling and angiogenesis.
  • To assess the therapeutic potential of NPY-based drugs for cardiovascular diseases.

Main Methods:

  • Literature review of existing research on Neuropeptide Y (NPY) and cardiac function.

Related Experiment Videos

  • Analysis of studies on NPY receptor subtypes (Y(1), Y(2), Y(5)) in the heart.
  • Examination of NPY's effects on endothelial cells, vascular smooth muscle cells, and cardiac myocytes.

    • Main Results:

    • NPY is released from sympathetic nerves and affects coronary arteries and myocardial contraction.
    • NPY exhibits mitogenic and hypertrophic effects on cardiac and vascular cells.
    • Elevated plasma NPY levels correlate with sympathetic activation in cardiac stress.
    • NPY and its receptor polymorphisms may increase risk for hypertension and cardiac complications.

    Conclusions:

    • Neuropeptide Y (NPY) may contribute to both beneficial and detrimental cardiac remodeling after injury.
    • NPY plays a role in angiogenic processes following myocardial ischemia.
    • Further mechanistic insights are needed to develop NPY-based therapies for heart disease.